Abstract For the purpose of a nationwide surveillance of the antimicrobial susceptibility of bacterial respiratory pathogens in patients in Japan, the Japanese Society of Chemotherapy conducted their second year survey, during the period from January to August, 2007 Haemophilus infl uenzae strains, 19.9% of them were found to be β-lactamase-non-producing ampicillin (ABPC)-intermediately-resistant (BLNAI), 29.1% to be β-lactamasenon-producing ABPC-resistant (BLNAR), and 6.7% to be β-lactamase-producing ABPC-resistant (BLPAR) strains.
Introduction
In order to investigate trends and changes in bacterial pathogens and the emergence of resistance among them, the Japanese Society of Chemotherapy (JSC) established a nationwide surveillance network in 2006. The fi rst survey was conducted during the period from January to August, 2006, with the cooperation of 32 medical institutions throughout Japan, and we reported trends in the antimicrobial susceptibilities of bacterial species from patients with respiratory tract infections (RTIs).
1 The fi rst surveillance, with a total of 924 strains, revealed the incidence of methicillin-resistant Staphylococcus aureus (MRSA) as 63. 4%, penicillin-intermediate-resistant and -resistant 
